Home > Salute > Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied... Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied StemCell's Gene Editing Platform and Oncology Product Portfolio ... di Redazione Notizie.it Pubblicato il 30 Gennaio 2020